Aggrenox: A Combination of Antiplatelet Drugs for Stroke Prevention
Aggrenox, a fixed-dose oral combination of aspirin and extended-release dipyridamole, is now being advertised for secondary prevention of a transient ischemic attack (TIA) or ischemic stroke....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Aggrenox: A Combination of Antiplatelet Drugs for Stroke Prevention
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1071
Article Code: 1071a
Date: February 7, 2000
Volume: 42
Pages: 11-12
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1071
Article Code: 1071a
Date: February 7, 2000
Volume: 42
Pages: 11-12
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)